21 st Working Group Meeting of the Scandinavian Sarcoma Group

Transcription

1 21 st Working Group Meeting of the Scandinavian Sarcoma Group December 5-6, 2016 Malmö PROGRAM Version

2 Introduction Welcome to the 21 st Scandinavian Sarcoma Group Working Committee Meeting in Malmø As usual all working committees have their own program and will discuss comprehensively selected topics. On Tuesday afternoon the Visceral and retroperitoneal sarcoma working group will have their own meeting (as previous years). Monday morning the first topic to be discussed is the SSG and possible tasks for the future. At the General assembly there will be election of three new board members. Information of the status of the central registry and proposals for collaborating on international register studies will follow. As previous years a PhD project bill be presented and this time a Norwegian chondrosarcomas project. Doctors and nurses are facing great challenges in their work with initiating/running studies, and many of these obstacles will be discussed. Our Danish colleagues will inform us about the program for the 38 th SSG Plenary Meeting in Aarhus on September 20-22, Deadline for abstracts May 1 st, Notably, our Scandinavian multidisciplinary cooperation is central in maintaining a high quality of diagnosis, treatment and follow-up of patients with bone- and soft tissue sarcoma. We should therefore strengthen such cooperation in the future. All chairmen of the working committees should send their report from the meeting to the SSG`s secretariat, our administrative secretary Eva-Mari Olofsson (Eva-Mari.Olofsson@med.lu.se) before December 18 th, Kirsten Sundby Hall, chairman Mikael Eriksson, secretary Scandinavian Sarcoma Group

3 Content Introduction... 2 Program Sunday December 4, Monday December 5, Tuesday December 6, Working group meetings Orthopaedic surgery working group... 7 Imaging working group... 8 Medical oncology & Radiotherapy working groups... 9 Morphology/Tumor biology working group Nurses and Physiotherapists working group Central register working group Visceral and retroperitoneal sarcoma working group... 13

4 Sunday December 4, Board meeting, Park Inn Chairmen: K. Sundby Hall, Oslo, O. Brosjö, Stockholm

5 Registration in Tokyo, WTC Monday December 5, Joint meeting, Meeting room: WTC Tokyo Chairmen: K. Sundby Hall, Oslo, O. Brosjö, Stockholm The present and the future of SSG K. Sundby Hall, Oslo, M. Eriksson, Lund General assembly with elections of new board members O-J Norum, K. Sundby Hall, Oslo, M. Eriksson, Lund Coffee The present status & future of the SSG central register E. Styring, Lund Ongoing SSG trials M. Eriksson, Lund, K. Sundby Hall, Oslo What are the challenges when initiating and performing clinical sarcoma trials today? J. Ceberg, M. Eriksson, Lund Chondrosarcoma a Norwegian national project J. Thorkildsen, Oslo SSG Plenary meeting Aarhus 2017 J. Keller, Aarhus Lunch (Restaurant Novel at WTC) SSG working group meetings Dinner, Restaurant Novel at WTC

6 Registration in Tokyo, WTC Tuesday December 6, Cont. SSG working group meetings Coffee Joint meeting, Meeting room: WTC Tokyo Chairmen: K. Sundby Hall, Oslo, O. Brosjö, Stockholm Reports from all groups SSG Morphology/Tumor biology group J. Wejde, Stockholm SSG Orthopaedic surgery group H, Jónsson Jr, Reykjavik SSG Imaging group M. Skorpil, Stockholm SSG Medical oncology & Radiotherapy group K. Sundby Hall, Oslo, M. Eriksson, Lund SSG Nurse and Physiotherapists group C. Våde, Oslo SSG Central register group E. Styring, Lund Lunch (Restaurant Novel at WTC) SSG Visceral and retroperitoneal sarcoma working group Meeting room: WTC Tokyo

7 Date: December 5, 2016, December 6, 2016, Place: Chairman: Agenda Orthopaedic surgery working group Meeting room: WTC Shanghai H, Jónsson, Reykjavik Lungmetastases in OS O. Brosjö, Stockholm Vascular complication after Polidocanol for ABC K. Pulverer, Oslo Non-invasive simultaneaous lengthening of tibia and femur with Bio-Xpand MUTARS/fit-Bone prosthesis C. Trovik, Bergen Arthrodesnail: A solution for limb salvage in infected tumorknee prosthesis P. Bergh, Gothenburg Bone reconstruction with autograft: Pretreatment with cryo-, radio- or autoclave P. Bergh, Gothenburg The use of Cement with antibiotics in the treatment of infections P. Bergh, Gothenburg Case report on a patient with Bio-expand prosthesis P. Bergh, Gothenburg 3D-printed prosthesis and resection guides in pelvic tumor surgery- an update M. Farhang, Umeå Sarcoma of extremity and trunk wall in Iceland H. Jónsson, Reykjavik Case reports from resp. collegues that have been presented during Internet Discussion

8 Date: December 5, 2016, December 6, 2016, Place: Chairman: Meeting room: WTC Abu Dhabi M. Skorpil, Stockholm Imaging working group Agenda Election of new chairman for the Imaging Group Presentation and discussion of interesting cases from participants of the Imaging Group Future methods. Discussion and journal club Real-time fusion of ultrasound and MRI/CT for diagnostics, injections and biopsies 18F-Sodium Flouride PET versus scintigraphy PET/MRI Report on the value of Dixon sequences in sarcoma imaging. Radiology Department, Umeå University Hospital. Upcoming 38 th Plenary Meeting in Aarhus, September 20-22, Other topics

9 Medical oncology & Radiotherapy working group Date: December 5, 2016, December 6, 2016, Place: Chairmen: Meeting room: WTC Tokyo K. Boye, Oslo, M. Eriksson, Lund, Agenda Olaratumab in STS; an update Should we use eribulin for metastatic liposarcoma? Pemprolizumab in osteosarcoma and MPNST; update on two phase II studies in Oslo High-dose therapy in Ewing sarcoma; results from EURO-E.W.I.N.G 99 Is bone marrow biopsy necessary in Ewing sarcoma? Functional outcome after surgery and radiotherapy for STS Short study updates: SSG XX EUROBOSS reecur DOREMY Legal issues with SSG as a sponsor of clinical trials Should we make Scandinavian guidelines for metastatic STS?

10 Morphology/Tumor biology working group Date: December 5, 2016, December 6, 2016, Place: Chairman: Meeting room: WTC Curacao J. Wejde, Stockholm, F. Mertens, Lund Agenda Election of new chairman for tumor biology Future topics for re-evaluation of bone and soft tissue tumors in the SSG registry Discussion about entities that could be of clinical and biological interest to evaluate both morphologically and genetically. Which analytical methods are feasible? Who could do what? Examples of entities that would be of interest: EWSR1-negative Ewing sarcomas, pleomorphic myxoid liopsarcoma, epithelioid fibrosarcoma, sarcomas with late (>5 years) relapse, myoepithelial tumors, inflammatory leiomyosarcoma, etc Upcoming 38 th Plenary Meeting in Aarhus, September 20-22, 2017

11 Nurses and Physiotherapists working group Date: December 5, 2016, December 6, 2016, Place: Chairman: Meeting room: WTC New York C. Våde, Oslo Agenda NoSarC A national study of gene mutations in sarcomas S. Næss, Oslo Standardised care process for subcutananeos and musculo-skeletal sarcoma in Sweden A. Pettersson, Umeå Life with neurofibromatosis transforming to malignant disease. S. Granlien, Oslo Report from Sarkomdagen in Lund September 24, E-M. Olofsson, Lund Follow up of the closest relatives to the patient who has died L. Utne Høiland, Bergen Physical activity and cancer M. Lia Johansen, Oslo Upcoming 38 th Plenary Meeting in Aarhus, September 20-22, Other topics

12 Central register working group Date: December 6, 2016, Place: Meeting room: Hotel Park Inn Conference room C Chairman: E. Styring, Lund Agenda Election of chairman for the register subcommittee (Emelie Styring, Lund, is one candidate. New candidates are welcome!) Decision on how to structure the register collaboration in the future. Adjustments of presented structure? Creation of working group with the mission of defining the guidelines for the collaboration and co-authorships in future studies. Discussion on which variables are key variables that we should strive after keeping the same/adapting to each other between the nation quality registers? Joint annual report? Other topics

13 Visceral and retroperitoneal sarcoma working group Date: December 6, 2016, Place: Meeting room: WTC Tokyo Chairmen: J. Åhlén, Stockholm, T. Hølmebakk, Oslo Agenda Definition and significance of tumor rupture in GIST T. Hølmebakk, Oslo Prediction of long-term survival in GIST: Analysis of a large, single institution patient cohort K. Boye, Oslo Status of ongoing GIST-studies (SSG XXII and ALT-GIST) in SSG M. Eriksson, Lund The STOP-GIST study: Discontinuation of imatinib in patients with oligometastatic gastrointestinal stromal tumor thas has been become radiologically undetecteble with treatment K. Boye, Oslo Neoadjuvant imatinib for GIST: For whom and for how long T. Hølmebakk, K. Boye, Oslo A new study on crenolanib in advanced GIST with D 842 mutation K. Sundby Hall, Oslo Neoadjuvant radiotherapy for retroperitoneal sarcoma: Should we seek a common Scandinavian practice? General discussion introduces by T. Hølmebakk, Oslo Other topics

14 Notes Notes

15

16 World Trade Center Malmö Jungmansgatan 12 SE Malmö Phone: Park Inn by Radisson Malmö Hotel Sjömansgatan 2 SE Malmö Phone: info.malmo@rezidorparkinn.com Scandinavian Sarcoma Group SSG secretariat Lund University Institution of Clinical Sciences Department of Cancer Epidemiology Kamprad 5th floor, Barngatan 2B SE Lund ssg@med.lu.se